Okay, let's tackle this question. The user provided a question about NIDDM and fundus examination but didn't list the options. Hmm, maybe the options got lost in the formatting. Anyway, the correct answer is likely related to the frequency of fundus exams in non-insulin-dependent diabetes mellitus, which is type 2 diabetes.

First, the core concept here is diabetic retinopathy. Since NIDDM is type 2 diabetes, the fundus exam is crucial for early detection of retinal changes. The American Diabetes Association guidelines recommend annual eye exams for all diabetics once they're diagnosed. Wait, but maybe there's a specific timing after diagnosis? I think initially, they should have an exam at diagnosis and then annually. But the question might be about the frequency.

The correct answer would probably be that fundus examination is done annually. Let me check the options. If the options were like "At diagnosis and every year," that's the right answer. The other options might suggest less frequent exams, like every 2-3 years, which is incorrect for type 2. Diabetic retinopathy can progress quickly, so annual exams are necessary.

Now, the clinical pearl is that early detection through fundus exams prevents vision loss. The high-yield fact is that annual screening is a standard of care. The user might have had options where one says "every 2 years" or "only when symptoms occur," which are wrong because symptoms appear late. So, the wrong options are incorrect because they don't follow the recommended guidelines.

I need to make sure the explanation is accurate. The core concept is diabetic retinopathy screening. The correct answer is annual exams. The incorrect options are less frequent or not following guidelines. The clinical pearl is the importance of annual screening. Got it.

**Core Concept**
Non-insulin-dependent diabetes mellitus (NIDDM, type 2 diabetes) is associated with **diabetic retinopathy**, a leading cause of preventable blindness. Regular **fundus examination** is critical for early detection of retinal vascular changes, including microaneurysms, cotton wool spots, and neovascularization.

**Why the Correct Answer is Right**
Annual fundus examination is the standard of care for **all diabetic patients**, including NIDDM, to monitor for retinopathy. This allows early intervention (e.g., laser photocoagulation, anti-VEGF therapy) to prevent vision loss. The American Diabetes Association (ADA) recommends **annual screening** starting at diagnosis and continuing indefinitely, as retinopathy can develop or progress even in long-standing diabetes.

**Why Each Wrong Option is Incorrect**
**Option A:** "Only if visual symptoms develop" – Incorrect. Diabetic retinopathy is often asymptomatic until advanced stages (e.g., vitreous hemorrhage), making routine screening essential.
**Option B:** "Every 2–3 years in stable patients" – Incorrect. Even stable patients require annual exams, as retinopathy can progress silently.
**Option C:** "Only in patients with poor glycemic control" – Incorrect. Poor glycemic control accelerates retinopathy but does not negate the need for annual screening in all patients.

**Clinical Pearl / High-Yield Fact**
Diabetic retinopathy is the **most common microvascular complication** of diabetes. Annual fundus exams are a **high

✓ Correct Answer: A. At the time of diagnosis